date,title,source
Nov-12-18,Cellectar Announces FDA Grants Exemption to Import Alert for CLR 131 Hematology Studies,GlobeNewswire
Nov-13-18,Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-21-18,Analysts Take Action on Health Care Stocks,GuruFocus.com
Dec-04-18,Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma,GlobeNewswire
Dec-11-18,Cellectar Granted Japanese Patent for CLR 131,GlobeNewswire
